Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.03 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | 3 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 9 Parkinson's papers of 343 | 0.70 |
| pathways Reactome | 12 pathways; mostly mitochondrial quality control | 1.00 |
No case: the score is under the bar. Receipt 6395
Sealed predictions
- CYCS in dopamine neurons, braak+0.20 (p 0.613) → +0.16 (p 0.672)receipt 6402
Swarm cases
receipt 6402: CYCS in dopamine neurons, braak
- power
- full sample +0.16 (p 0.521, n 18), 95% CI -0.33 to +0.58. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.15 (p 0.561, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.13 (p 0.597, n 18). could be the mix.
- skeptic
- leave-one-out range +0.06 to +0.30, sign flips 0; without severely affected donors +0.16 (p 0.521, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CYCS in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts